Laboratorija tiria tik tą mėginį, kuris buvo jai pateiktas. Tai reiškia, kad tyrimo rezultatas patvirtina konkretaus mėginio sudėtį tuo metu, kai jis buvo ištirtas, bet automatiškai negarantuoja, kad kiekvienas vėliau parduotas buteliukas yra iš tos pačios partijos.

Once dismissed as a mere waste product of insulin synthesis, C-peptide is emerging as a potentially active molecule with its own biological roles worth studying.

Researchers are investigating whether peptides can slow aging and accelerate tissue repair, but most evidence so far comes from labs and animal models.

Scientists are tackling the formidable chemistry challenge of turning peptide therapies into pills that survive the harsh journey through the human digestive system.

Scientists are uncovering a hidden layer of the human proteome encoded in regions of DNA long thought to be non-coding, potentially reshaping our understanding of cellular biology.

Researchers are investigating AI-driven tools to speed up the identification of antimicrobial peptides, a field where traditional methods have long struggled to keep pace with rising drug resistance.

Peptides dominate skincare marketing, yet researchers say the evidence behind many topical claims remains thin, inconsistent, or largely preclinical.

An upcoming FDA advisory panel on peptides has drawn scrutiny after reports that some invited experts have publicly promoted compounds that lack regulatory approval.

New analysis suggests the FDA is pushing impurity limits for peptide compounds as low as 0.10%, signalling closer regulatory scrutiny of the fast-growing sector.

FDA researchers have voiced concerns about peptides gaining popularity without sufficient safety oversight, highlighting gaps in how these molecules are currently regulated.

Researchers and regulators are raising alarms as unverified GLP-1 receptor agonist peptides circulate through informal channels outside clinical oversight.

Scientists are turning attention to the 'dark proteome'—poorly understood or uncharacterised proteins—as a potential new frontier in cancer biology.

A new collaboration between LG AI Research and D&D Pharmatech aims to apply artificial intelligence to one of peptide science's longest-standing challenges: making peptides work as oral drugs.

Copper peptides have become a focal point of skincare research and product development, but what does the evidence behind them actually show?

A new AI-focused partnership aims to overcome the longstanding challenge of making peptide drugs that work when swallowed rather than injected.

A California lawmaker is pushing for a formal peptide working group, signalling that regulatory scrutiny of the fast-growing peptide sector may be intensifying.

Excellent company, have social media groups that are very helpful, delivery was literally next day, Can’t fault J&C will definitely be back

LG AI Research and South Korean biotech D&D Pharmatech have announced a collaboration aimed at accelerating the discovery of next-generation oral peptide therapeutics using artificial intelligence.

As peptides surge in popularity online, scientists and clinicians urge caution, noting that rigorous human evidence for many promoted compounds remains limited.

LG AI Research and D&D Pharmatech have announced a collaboration aimed at using artificial intelligence to speed up the discovery of next-generation oral peptide drugs.

LG AI Research is applying machine-learning tools to discover orally bioavailable peptide drug candidates, reflecting a broader industry shift toward AI-driven molecular design.

A surge in commercial and research interest in peptides is raising questions about oversight, quality standards, and what the science actually supports.

Researchers have developed a more accurate technique for identifying short peptides concealed within complex biological sources like food and human tissues.

Researchers are turning to natural biological systems for inspiration, using nature's own molecular designs to drive innovation in peptide-based biotechnology.

Stanford scientists are investigating naturally produced peptides that may mimic GLP-1 receptor activity, raising questions about homegrown alternatives to drugs like semaglutide.

Scientists are raising concerns that the rapid online spread of injectable research peptides is moving faster than existing regulatory frameworks can handle.

Looking to enhance your research with high-quality peptides? You've come to the right place! At Peptides Lookup, we’re committed to providing premium-grade peptides to fuel your sc

BSCG has raised concerns that unregulated peptides and research chemicals pose growing reputational risks for the sports nutrition and supplement sectors.

Strategic collaborations between specialised firms are accelerating the development of peptide drug conjugates, a class of therapies designed to deliver active compounds with greater precision.

A peptide first identified by Croatian scientists decades ago is now attracting wide attention in the US, reigniting interest in early-stage research.

UCF-led research is exploring how peptides might disrupt the protective biofilm structures that make certain bacterial infections notoriously hard to treat.

Specialised wholesale programs for research-grade peptides are expanding access for laboratories, resellers, and biotech teams navigating early-stage peptide science.

Delta sleep-inducing peptide (DSIP) has attracted growing scientific interest, though most findings remain at the preclinical stage.

A PhD student team from PolyU won the Grand Prize at a major Hong Kong innovation competition for their peptide-focused cancer therapy research.

Structural changes in the peptide supply chain are prompting researchers and industry observers to explore alternative marketplace approaches.

Eloratlintide is a novel investigational peptide designed to target metabolic pathways involved in appetite regulation and energy balance. It is being studied for its potential rol

A growing wave of enthusiasm for therapeutic peptides is colliding with a more cautious scientific reality, raising questions about what the research truly supports.

A supplier's launch of COA-verified BPC-157 highlights growing calls for standardised reference compounds as preclinical peptide research expands.

Researchers are exploring whether longitudinal C-peptide measurement could serve as a more robust endpoint in Type 1 diabetes clinical trials.

Scientists are investigating peptides as potential therapeutic tools, but experts urge caution as much of the supporting evidence remains early-stage or animal-based.

Coming from here? Use this special 15% discount code in BUFFROIDS: PEPLOOKUP15! Valid until 2026-12-31

Researchers and formulators are increasingly looking at clinical amino acid data to guide the development of natural peptide supplements, but questions remain about efficacy.

A pharmacist-led discussion around RFK Jr.'s peptide reclassification announcement is prompting fresh scrutiny of how these compounds are regulated in the U.S.

Scientists and clinicians are weighing in on what current evidence does and does not tell us about the safety and biological activity of therapeutic peptides.